{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-447550","form_type":"8-K","ticker":"RLYB","cik":"0001739410","company_name":"Rallybio Corp","filed_at":"2026-11-04T21:58:47+00:00","discovered_at":"2026-11-04T22:00:00.526689+00:00","generated_at":"2026-11-04T22:00:05.786514+00:00","sec_items":["5.02","5.07","8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Rallybio holders approve Avenzo merger and $13.90/share cash distribution; close expected Nov. 6","bullets":["All eight annual-meeting proposals passed; Proposal 1, issuing Rallybio stock to Avenzo holders (>20% and a change of control), won 4,506,703 for vs 15,979 against.","Special cash distribution set at $83.6 million, or $13.90 per share, to holders of record Nov. 5, 2026; transfer agent payment expected Nov. 13, 2026.","Stock trades with due bills Nov. 5-6, 2026 ahead of the Nov. 9 ex-dividend date; investors must hold through the Nov. 6 close to receive the distribution.","Merger expected to close Nov. 6, 2026; Rallybio will be renamed Avenzo Therapeutics, raise authorized shares to 500M from 200M, with a 1-for-2 to 1-for-9 reverse split not done pre-close.","Avenzo 2026 Equity Incentive Plan reserve equals 18% of post-merger shares outstanding; 2026 ESPP reserve 1%, each with annual evergreen increases through 2036."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-447550","json":"https://secwatch.observer/filing/0001193125-26-447550.json","markdown":"https://secwatch.observer/filing/0001193125-26-447550.md","text":"https://secwatch.observer/filing/0001193125-26-447550.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1739410/000119312526447550/0001193125-26-447550-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1739410/000119312526447550/d164725d8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-11-04T22:00:05.786514+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}